HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter K Kaiser Selected Research

Retinal Vasculitis

1/2022Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map.
1/2021Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
4/2007Intravitreal bevacizumab for macular edema due to occlusive vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter K Kaiser Research Topics

Disease

86Macular Degeneration (Age-Related Maculopathy)
02/2024 - 03/2003
29Macular Edema
10/2023 - 07/2002
27Choroidal Neovascularization
01/2022 - 03/2005
17Retinal Perforations
01/2023 - 11/2006
16Diabetic Retinopathy (Retinopathy, Diabetic)
10/2023 - 07/2007
13Endophthalmitis (Ophthalmia)
01/2021 - 01/2003
12Uveitis
05/2017 - 07/2002
11Inflammation (Inflammations)
05/2024 - 12/2004
8Retinal Vein Occlusion
10/2017 - 06/2005
7Epiretinal Membrane (Epiretinal Membranes)
01/2022 - 12/2010
6Retinal Diseases
07/2024 - 01/2019
6Hemorrhage
01/2019 - 07/2002
5Wounds and Injuries (Trauma)
01/2017 - 02/2008
4Retinal Detachment (Retinal Detachments)
02/2010 - 09/2006
3Geographic Atrophy
11/2023 - 11/2022
3Polypoidal Choroidal Vasculopathy
11/2022 - 05/2013
3Central Serous Chorioretinopathy
11/2022 - 01/2015
3Retinal Vasculitis
01/2022 - 04/2007
3Atrophy
11/2018 - 05/2011
3Vitreous Detachment (Posterior Vitreous Detachment)
10/2017 - 11/2013
3Myopia
01/2016 - 03/2003
3Neoplasms (Cancer)
01/2016 - 11/2006
3Posterior Uveitis
10/2011 - 10/2008
2Eye Diseases (Eye Disease)
07/2024 - 10/2022
2Vitreous Hemorrhage
01/2012 - 11/2007
2Glaucoma
08/2008 - 10/2007
2Cataract (Cataracts)
11/2007 - 05/2005
2Retinitis
06/2007 - 02/2007
2Ischemia
04/2007 - 11/2006
2Histoplasmosis
01/2004 - 03/2003
1Vascular Diseases (Vascular Disease)
05/2024
1Choroidal Effusions
03/2024
1Disease Progression
10/2023
1Protein Deficiency
01/2022
1Confusion (Bewilderment)
01/2022
1Chronic Disease (Chronic Diseases)
01/2022
1Blister (Bulla)
12/2021
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2021
1Polyps
01/2020
1Neuritis (Polyneuritis)
01/2016
1Optic Neuritis (Retrobulbar Neuritis)
01/2016
1Ganglion Cysts (Ganglion)
01/2016
1Type 2 Diabetes Mellitus (MODY)
02/2015

Drug/Important Bio-Agent (IBA)

41Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2024 - 10/2006
37Retinaldehyde (Retinal)IBA
05/2024 - 07/2002
32Ranibizumab (Lucentis)FDA Link
01/2022 - 10/2006
24afliberceptIBA
08/2023 - 03/2012
13Verteporfin (Visudyne)FDA Link
11/2022 - 03/2003
13Bevacizumab (Avastin)FDA Link
01/2017 - 04/2007
71-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2022 - 12/2007
6Fluorescein (Funduscein)FDA LinkGeneric
01/2021 - 02/2003
6Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
02/2008 - 11/2003
6SteroidsIBA
10/2007 - 12/2004
5salicylhydroxamic acid (SHAM)IBA
10/2023 - 10/2006
5Triamcinolone (Aristocort)FDA Link
02/2008 - 07/2002
4brolucizumabIBA
08/2023 - 01/2021
3risuteganibIBA
11/2022 - 01/2021
3Ophthalmic Solutions (Eye Drops)IBA
10/2022 - 05/2015
3KH902 fusion proteinIBA
01/2020 - 01/2019
3microplasminIBA
12/2018 - 03/2014
3Monoclonal AntibodiesIBA
01/2016 - 10/2006
3Fluocinolone Acetonide (Capex)FDA LinkGeneric
10/2011 - 02/2007
2Complement System Proteins (Complement)IBA
11/2023 - 01/2016
2PlacebosIBA
10/2023 - 10/2007
2Endothelial Growth FactorsIBA
09/2020 - 01/2017
2Mineralocorticoid Receptor AntagonistsIBA
01/2020 - 01/2015
2Eplerenone (Inspra)FDA LinkGeneric
01/2020 - 01/2015
2Angiogenesis InhibitorsIBA
01/2016 - 10/2006
2Retinal Pigments (Pigments, Visual)IBA
02/2010 - 06/2007
2anecortave acetateIBA
01/2007 - 02/2006
1Proteins (Proteins, Gene)FDA Link
07/2024
1Angiopoietin-2IBA
07/2024
1Complement C3 (C3 Complement)IBA
11/2023
1faricimabIBA
09/2023
1formycin diphosphate (FDP)IBA
01/2023
1IntegrinsIBA
10/2022
1Biosimilar PharmaceuticalsIBA
01/2022
1Capsules (Microcapsules)IBA
12/2021
1regorafenibIBA
01/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2018
1CollagenIBA
01/2017
1Vascular Endothelial Growth FactorsIBA
01/2017
1Therapeutic UsesIBA
01/2017

Therapy/Procedure

37Therapeutics
02/2024 - 05/2005
15Vitrectomy
12/2021 - 11/2006
13Intravitreal Injections
01/2023 - 11/2003
11Injections
11/2021 - 10/2006
9Lasers (Laser)
05/2024 - 11/2006
9Traction
10/2017 - 09/2006
8Light Coagulation
10/2023 - 11/2006
8Photochemotherapy (Photodynamic Therapy)
05/2012 - 03/2003
3Retreatment
10/2023 - 12/2012
3Radiotherapy
09/2013 - 06/2009
2Intraocular Injections
05/2024 - 11/2006
2Aftercare (After-Treatment)
09/2020 - 01/2003
2Slit Lamp
05/2017 - 08/2016
2Cataract Extraction
08/2007 - 12/2004
1Duration of Therapy
01/2023
1Autologous Transplantation
12/2021
1Transplantation
12/2021